|
1) Takayasu K, Muramatsu Y, Mizoguchi Y, et al. CT evaluation of the progression of hypoattenuating nodular lesions in virus-related chronic liver disease. AJR. 2006; 187: 454-63
|
|
|
|
|
2) Kobayashi M, Ikeda K, Hosaka T, et al. Dysplastic nodules frequently develop into hepatocellular carcinoma in patients with chronic viral hepatitis and cirrhosis. Cancer. 2006; 106: 636-47
|
|
|
|
|
3) Iannaccone R, Piacentini F, Murakami T, et al. Hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: helical CT and MR imaging findings with clinical-pathologic comparison. Radiology. 2007; 243: 422-30
|
|
|
|
|
|
4) Ikeda K, Kobayashi M, Saitoh S, et al. Origin of neovascular structure in an early stage of hepatocellular carcinoma: study of alpha-smooth muscle actin immunohistochemistry in serial thin sections of surgically resected cancer. J Gastroenterol Hepatol. 2006; 21: 183-90
|
|
|
|
|
|
5) Kim CK, Lim JH, Park CK, et al. Neoangiogenesis and sinusoidal capillarization in hepatocellular carcinoma: correlation between dynamic CT and density of tumor microvessels. Radiology. 2005; 237: 529-34
|
|
|
|
|
|
6) Kanematsu M, Osada S, Amaoka N, et al. Expression of vascular endothelial growth factor in hepatocellular carcinoma and the surrounding liver: correlation with MR imaging and angiographically assisted CT. Abdom Imaging. 2006; 31: 78-89
|
|
|
|
|
|
7) Sanada Y, Yoshida K, Itoh H. Comparison of CT enhancement patterns and histologic features in hepatocellular carcinoma up to 2 cm: assessment of malignant potential with claudin-10 immunohistochemistry. Oncol Rep. 2007; 17: 1177-82
|
|
|
|
|
|
8) Goshima S, Kanematsu M, Kondo H, et al. MDCT of the liver and hypervascular hepatocellular carcinomas: optimizing scan delays for bolus-tracking techniques of hepatic arterial and portal venous phases. AJR. 2006; 187: W25-32
|
|
|
|
|
|
9) Kim MJ, Choi JY, Lim JS, et al. Optimal scan window for detection of hypervascular hepatocellular carcinomas during MDCT examination. AJR. 2006; 187: 198-206
|
|
|
|
|
|
10) Ichikawa T, Nakajima H, Nanbu A, et al. Effect of injection rate of contrast material on CT of hepatocellular carcinoma. AJR. 2006; 186: 1413-8
|
|
|
|
|
|
11) Doyle DJ, O'Malley ME, Jang HJ, et al. Value of the unenhanced phase for detection of hepatocellular carcinomas 3 cm or less when performing multiphase computed tomography in patients with cirrhosis. J Comput Assist Tomogr. 2007; 31: 86-92
|
|
|
|
|
|
12) Monzawa S, Ichikawa T, Nakajima H, et al. Dynamic CT for detecting small hepatocellular carcinoma: usefulness of delayed phase imaging. AJR. 2007; 188: 147-53
|
|
|
|
|
|
13) Funama Y, Awai K, Miyazaki O, et al. Improvement of low-contrast detectability in low-dose hepatic multidetector computed tomography using a novel adaptive filter: evaluation with a computer-simulated liver including tumors. Invest Radiol. 2006; 41: 1-7
|
|
|
|
|
|
14) Miyamoto N, Sakurai Y, Nishimori H, et al. Optimal scan timing for coronal enhancement of hypervascular hepatocellular carcinomas and correlation with tumor size: evaluation with four-phase CT hepatic arteriography. Radiat Med. 2005; 23: 456-62
|
|
|
|
|
15) Okumura E, Sanada S, Suzuki M, et al. A computer-aided temporal and dynamic subtraction technique of the liver for detection of small hepatocellular carcinomas on abdominal CT images. Phys Med Biol. 2006; 51: 4759-71
|
|
|
|
|
|
16) Kim YK, Kwak HS, Kim CS, et al. Hepatocellular carcinoma in patients with chronic liver disease: comparison of SPIO-enhanced MR imaging and 16-detector row CT. Radiology. 2006; 238: 531-41
|
|
|
|
|
|
17) Zhao H, Yao JL, Wang Y, et al. Detection of small hepatocellular carcinoma: comparison of dynamic enhancement magnetic resonance imaging and multiphase multirow-detector helical CT scanning. World J Gastroenterol. 2007; 13: 1252-6
|
|
|
|
|
|
18) Yukisawa S, Okugawa H, Masuya Y, et al. Multidetector helical CT plus superparamagnetic iron oxide-enhanced MR imaging for focal hepatic lesions in cirrhotic liver: a comparison with multi-phase CT during hepatic arteriography. Eur J Radiol. 2007; 61: 279-89
|
|
|
|
|
|
19) Imai Y, Murakami T, Hori M, et al. Hypervascular hepatocellular carcinoma: Combined dynamic MDCT and SPIO-enhanced MRI versus combined CTHA and CTAP. Hepatol Res. 2007 (in print)
|
|
|
|
|
|
20) Wang JH, Lu SN, Hung CH, et al. Small hepatic nodules (＜or＝2cm) in cirrhosis patients: characterization with contrast-enhanced ultrasonography. Liver Int. 2006; 26: 928-34
|
|
|
|
|
|
21) Maruyama H, Kobayashi S, Yoshizumi H, et al. Application of percutaneous ultrasound-guided treatment for ultrasonically invisible hypervascular hepatocellular carcinoma using microbubble contrast agent. Clin Radiol. 2007; 62: 668-75
|
|
|
|
|
|
22) Yamamoto K, Shiraki K, Nakanishi S, Fuke H, et al. 1. 5 Harmonic Imaging Sonography with microbubble contrast agent improves characterization of hepatocellular carcinoma. World J Gastroenterol. 2005; 11: 5607-13
|
|
|
|
|
|
23) Nicolau C, Vilana R, Catala V, et al. Importance of evaluating all vascular phases on contrast-enhanced sonography in the differentiation of benign from malignant focal liver lesions. AJR Am J Roentgenol. 2006; 186: 158-67
|
|
|
|
|
|
24) Wu W, Chen MH, Yin SS, et al. The role of contrast-enhanced sonography of focal liver lesions before percutaneous biopsy. AJR. 2006; 187: 752-61
|
|
|
|
|
|
25) Jung EM, Kubale R, Jungius KP, et al. Vascularization of liver tumors - preliminary results with Coded Harmonic Angio (CHA), phase inversion imaging, 3D power Doppler and contrast medium-enhanced B-flow with second generation contrast agent (Optison). Clin Hemorheol Microcirc. 2006; 34: 483-97
|
|
|
|
|
|
26) Catalano O, Sandomenico F, Nunziata A, et al. Transient hepatic echogenicity difference on contrast-enhanced ultrasonography: sonographic sign and pitfall. J Ultrasound Med. 2007; 26: 337-45
|
|
|
|
|
|
27) Tatsugami F, Matsuki M, Nakai G, et al. Hepatic computed tomography for simultaneous depiction of hepatocellular carcinoma, intrahepatic portal veins, and hepatic veins in real-time virtual sonography: Initial experience. J Ultrasound Med. 2007; 26: 1065-9
|
|
|
|
|
|
28) Hirooka M, Iuchi H, Kumagi T, et al. Virtual sonographic radiofrequency ablation of hepatocellular carcinoma visualized on CT but not on conventional sonography. AJR Am J Roentgenol. 2006; 186: S255-60
|
|
|
|
|
|
29) Hotta N, Maeno T, Ayada M, et al. Four-dimensional ultrasonography for therapeutic radiofrequency ablation for hepatocellular carcinoma. Hepatogastroenterology. 2006; 53: 521-5
|
|
|
|
|
|
30) Talbot JN, Gutman F, Fartoux L, et al. PET/CT in patients with hepatocellular carcinoma using [(18)F]fluorocholine: preliminary comparison with [(18)F]FDG PET/CT. Eur J Nucl Med Mol Imaging. 2006; 33: 1285-9
|
|
|
|
|
|
31) Ho CL, Chen S, Yeung DW, et al. Dual-tracer PET/CT imaging in evaluation of metastatic hepatocellular carcinoma. J Nucl Med. 2007; 48: 902-9
|
|
|
|
|
|
32) Matake K, Yoshimitsu K, Kumazawa S, et al. Usefulness of artificial neural network for differential diagnosis of hepatic masses on CT images. Acad Radiol. 2006; 13: 951-62
|
|
|
|
|
|
33) Park HS, Lee SH, Kim YI, et al. Postbiopsy arterioportal fistula in patients with hepatocellular carcinoma: clinical significance in transarterial chemoembolization. AJR. 2006; 186: 556-61
|
|
|
|
|
|
34) Dill-Macky MJ, Asch M, Burns P, et al. Radiofrequency ablation of hepatocellular carcinoma: predicting success using contrast-enhanced sonography. AJR. 2006; 186: S287-95
|
|
|
|
|
|
35) Wang JH, Lu SN, Tung HD, et al. Flash-echo contrast sonography in the evaluation of response of small hepatocellular carcinoma to percutaneous ablation. J Clin Ultrasound. 2006; 34: 161-8
|
|
|
|
|
|
36) Imai Y, Okamoto N, Tateiwa N, et al. Assessment of treatment efficacy in radiofrequency ablation for hepatocellular carcinoma: Comparison between multiplanar reconstruction by multi-detector row CT and contrast-enhanced ultrasonography by Truagent detection mode. Hepatol Res. 2006; 35: 69-75
|
|
|
|
|
|
37) Filippone A, Iezzi R, Di Fabio F, et al. Multidetector-row computed tomography of focal liver lesions treated by radiofrequency ablation: spectrum of findings at long-term follow-up. J Comput Assist Tomogr. 2007; 31: 42-52
|
|
|
|
|
|
38) Kim YS, Rhim H, Lim HK, et al. Completeness of treatment in hepatocellular carcinomas treated with image-guided tumor therapies: Evaluation of positive predictive value of contrast-enhanced CT with histopathologic correlation in the explanted liver specimen. J Comput Assist Tomogr. 2006; 30: 578-82
|
|
|
|
|